Astrazeneca Pharma India informs about loss of share certificate

02 Jan 2020 Evaluate

Pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015, Astrazeneca Pharma India has informed that the Company is intimating the request received relating to Loss of share certificate and issue of duplicate share certificate as per attached details.

The above information is a part of company’s filings submitted to BSE.


Astrazeneca Pharma I Share Price

9211.50 22.60 (0.25%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×